Bacitracin in DrugAge

Summary

SpeciesAssaysAvg Lifespan Change (%)Maximum Lifespan Change (%)
Caenorhabditis elegans158.5 74
Summary Total Assays: 1 Max: 58.5 Max: 74

Results for Bacitracin

Species Avg Lifespan change (%) Max Lifespan change (%) Strain Dosage Gender Significance

Selected Lifespan Change:

Species Avg Lifespan change (%) Max Lifespan change (%) Strain Dosage Gender Significance Reference

References

Primary References
Lublin, A et al. (2011) FDA-approved drugs that protect mammalian neurons from glucose toxicity slow aging dependent on cbp and protect against proteotoxicity. PLoS ONE 6(11)e27762 PubMed

DGIdb human gene-drug interactions for Bacitracin

Entrez Gene Symbol Gene Name Interaction Source Interaction Type GenAge Interactions

Stitch DB human protein-drug interactions for Bacitracin

The data below is based on a Stitch DB API call for human protein-drug interactions for Bacitracin

Up to 20 direct protein and drug interactions are displayed, having a medium confidence score (0.450) or above.

Bacitracin

Displayed below are the associated biological networks for each of the top 20 direct Bacitracin protein interactors.

Ensembl Id StringDB Id